GTC Biotherapeutics (fka GTCB)

[floblu14]

>DIC is no slam-dunk.<

I repeat - err - DEW repeats -
>With a firm scientific grounding from the new preclinical data and an enhanced understanding of the ramifications of Kybersept, it would seem that GTC’s DIC program has a good chance to bear fruit.<

http://investorshub.advfn.com/boards/read_msg.asp?message_id=20150779

P.S. A toast to ATRYN, goatees. Drink up or be infused